Tag: Compass Pathways - Page 7 - Psychedelic Alpha

Read more about the article Guy Goodwin joins COMPASS Pathways as Chief Medical Officer

Guy Goodwin joins COMPASS Pathways as Chief Medical Officer

Post published:July 29, 2021
Post category:Press Release

Read more about the article COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

Post published:July 5, 2021
Post category:Press Release

Read more about the article COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”

COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”

Post published:June 30, 2021
Post category:Press Release

Read more about the article COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression

Post published:June 28, 2021
Post category:Press Release

Read more about the article COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme

COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme

Post published:June 23, 2021
Post category:Press Release

Read more about the article COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

Post published:June 3, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

Post published:May 13, 2021
Post category:Press Release

Read more about the article COMPASS Pathways announces pricing of public offering

COMPASS Pathways announces pricing of public offering

Post published:April 30, 2021
Post category:Press Release

Read more about the article COMPASS Pathways launches proposed public offering

COMPASS Pathways launches proposed public offering

Post published:April 27, 2021
Post category:Press Release

Read more about the article New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder

New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder

Post published:April 15, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.